182 related articles for article (PubMed ID: 25633287)
21. Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case-control study.
Wang MT; Lai JH; Huang YL; Kuo FC; Wang YH; Tsai CL; Tu MY
Respir Res; 2020 Dec; 21(1):319. PubMed ID: 33267895
[TBL] [Abstract][Full Text] [Related]
22. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.
Turner R; Cull C; Holman R
Ann Intern Med; 1996 Jan; 124(1 Pt 2):136-45. PubMed ID: 8554206
[TBL] [Abstract][Full Text] [Related]
23. Glycaemic instability is an underestimated problem in Type II diabetes.
Praet SF; Manders RJ; Meex RC; Lieverse AG; Stehouwer CD; Kuipers H; Keizer HA; van Loon LJ
Clin Sci (Lond); 2006 Aug; 111(2):119-26. PubMed ID: 16613586
[TBL] [Abstract][Full Text] [Related]
24. Intermediate hyperglycaemia and 10-year mortality in resource-constrained settings: the PERU MIGRANT Study.
Lazo-Porras M; Ruiz-Alejos A; Miranda JJ; Carrillo-Larco RM; Gilman RH; Smeeth L; Bernabé-Ortiz A
Diabet Med; 2020 Sep; 37(9):1519-1527. PubMed ID: 32181918
[TBL] [Abstract][Full Text] [Related]
25. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
[TBL] [Abstract][Full Text] [Related]
26. Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61.
Winzap P; Davies A; Klingenberg R; Obeid S; Roffi M; Mach F; Räber L; Windecker S; Templin C; Nietlispach F; Nanchen D; Gencer B; Muller O; Matter CM; von Eckardstein A; Lüscher TF
Cardiovasc Diabetol; 2019 Oct; 18(1):142. PubMed ID: 31672144
[TBL] [Abstract][Full Text] [Related]
27. Association between postprandial hyperglycemia at clinic visits and all-cause and cancer mortality in patients with type 2 diabetes: A long-term historical cohort study in Japan.
Takao T; Takahashi K; Suka M; Suzuki N; Yanagisawa H
Diabetes Res Clin Pract; 2019 Feb; 148():152-159. PubMed ID: 30641172
[TBL] [Abstract][Full Text] [Related]
28. Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study.
Pradhan R; Lu S; Yin H; Yu OHY; Ernst P; Suissa S; Azoulay L
BMJ; 2022 Nov; 379():e071380. PubMed ID: 36318979
[TBL] [Abstract][Full Text] [Related]
29. Risk of Future Type 2 Diabetes Mellitus in Patients Developing Steroid-Induced Hyperglycemia During Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation.
Upadhyay J; Trivedi N; Lal A
Lung; 2020 Jun; 198(3):525-533. PubMed ID: 32346783
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and determinants of hyperglycaemia in pneumonia patients.
Salonen PH; Koskela HO; Niskanen L
Scand J Infect Dis; 2013 Feb; 45(2):88-94. PubMed ID: 22991982
[TBL] [Abstract][Full Text] [Related]
31. Contribution of basal and postprandial hyperglycaemia in type 2 diabetes patients treated by an intensified insulin regimen: Impact of pump therapy in the OPT2mise trial.
Reznik Y; Habteab A; Castaneda J; Shin J; Joubert M
Diabetes Obes Metab; 2018 Oct; 20(10):2435-2441. PubMed ID: 29862649
[TBL] [Abstract][Full Text] [Related]
32. Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study.
Kar P; Plummer MP; Bellomo R; Jenkins AJ; Januszewski AS; Chapman MJ; Jones KL; Horowitz M; Deane AM
Crit Care Med; 2016 Sep; 44(9):1695-703. PubMed ID: 27315191
[TBL] [Abstract][Full Text] [Related]
33. Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil.
Schmidt MI; Bracco PA; Yudkin JS; Bensenor IM; Griep RH; Barreto SM; Castilhos CD; Duncan BB
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):267-277. PubMed ID: 30803929
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerability of vildagliptin in drug-naïve patients with type 2 diabetes and mild hyperglycaemia*.
Scherbaum WA; Schweizer A; Mari A; Nilsson PM; Lalanne G; Jauffret S; Foley JE
Diabetes Obes Metab; 2008 Aug; 10(8):675-82. PubMed ID: 18248490
[TBL] [Abstract][Full Text] [Related]
35. Hypoglycaemia is associated with increased length of stay and mortality in people with diabetes who are hospitalized.
Nirantharakumar K; Marshall T; Kennedy A; Narendran P; Hemming K; Coleman JJ
Diabet Med; 2012 Dec; 29(12):e445-8. PubMed ID: 22937877
[TBL] [Abstract][Full Text] [Related]
36. Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria.
Eide IA; Halden TA; Hartmann A; Åsberg A; Dahle DO; Reisaeter AV; Jenssen T
Transpl Int; 2016 May; 29(5):568-78. PubMed ID: 26875590
[TBL] [Abstract][Full Text] [Related]
37. Determinants of diagnostic discordance for non-diabetic hyperglycaemia and Type 2 diabetes using paired glycated haemoglobin measurements in a large English primary care population: cross-sectional study.
Bachmann MO; Lewis G; John WG; Turner J; Dhatariya K; Clark A; Pascale M; Sampson M;
Diabet Med; 2019 Nov; 36(11):1478-1486. PubMed ID: 31420897
[TBL] [Abstract][Full Text] [Related]
38. Relationship between HbA1c and indices of glucose tolerance derived from a standardized meal test in newly diagnosed treatment naive subjects with Type 2 diabetes.
Peter R; Luzio SD; Dunseath G; Pauvaday V; Mustafa N; Owens DR
Diabet Med; 2006 Sep; 23(9):990-5. PubMed ID: 16922705
[TBL] [Abstract][Full Text] [Related]
39. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.
Bonora E
Int J Clin Pract Suppl; 2002 Jul; (129):5-11. PubMed ID: 12166607
[TBL] [Abstract][Full Text] [Related]
40. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.
McFarlane SI; Chaiken RL; Hirsch S; Harrington P; Lebovitz HE; Banerji MA
Diabet Med; 2001 Jan; 18(1):10-6. PubMed ID: 11168335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
